N-SULFONYLTYROSINE 4-(4-PYRIDYL)-BUTYL ESTER OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND A METHOD OF SYNTHESIS OF N-SULFONYLTYROSINE 4-(4-PYRIDYL)-BUTYL ESTER OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS Russian patent published in 1998 - IPC

Abstract RU 2114105 C1

FIELD: organic chemistry. SUBSTANCE: product: N-sulfonyltyrosine 4-(4-pyridyl)-butyl ester of the formula (I) C4H9SO2Cl or its pharmaceutically acceptable salts. Reagent 1: tyrosine. Reagent 2: n-Br(CH2)4Cl. Reagent 3: methylated pyridine. Reagent 4: . Product of interaction of reagents 1 and 2 is subjected for reaction with product of interaction of reagents 3 and 4. Reaction conditions: in the presence of alkali. Product of the formula (I) is subjected for selective hydrogenation using Pd/C in acetic acid and product of the formula (II) is obtained. Synthesized compound is used in medicine as an antagonist of fibrinogen receptors. EFFECT: improved method of synthesis. 4 cl, 1 ex

Similar patents RU2114105C1

Title Year Author Number
METHOD OF SYNTHESIS OF TYROSINE DERIVATIVES 1994
  • Dzhon I.A.Chang[Us]
  • Dehvid L.Kh'Judzhes[Us]
  • Dehlian Zao[Cn]
RU2097377C1
METHOD FOR PRODUCTION OF TYROSINE DERIVATIVES 1993
  • Dzhon I.L.Chang
  • Dehvid L.Kh'Judzhes
  • Dehlian Zao
RU2113432C1
SUBSTITUTED HETEROCYCLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION FOR BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS, METHOD OF BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS 1993
  • Konrad P.Dorn
  • Dzheffri Dzh.Khejl
  • Mal'Kol'M Mehkkoss
  • Sander Dzh.Millz
  • Tamara Lehdduvakhetti
  • Shrenik K.Shakh
RU2140914C1
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS 1995
  • Konrad P. Dorn
  • Dzheffri Dzh. Khejl
  • Mal'Kol'M Makkoss
  • Sander G. Mills
RU2170233C2
CYCLIC PEPTIDES OR THEIR ADDITIVE ACID SALTS, A COMPOSITION SHOWING ANTIFUNGAL AND ANTIPNEUMOCYSTOSIS ACTIVITY, A METHOD OF TREATMENT OF PATIENTS WITH FUNGAL INFECTIONS 1994
  • Dzhejms M.Balkovek
  • Frehnsis Ehjlin Buffard
  • Regina M.Blehk
RU2122548C1
IMIDAZOLIDYLIC MACROLIDE OR ITS ISOMERS, OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE ACTIVITY 1992
  • Mark Goulet[Us]
  • Piter Dzh.Sinklejr[Us]
  • Frederik Vong[Us]
  • Mehtt'Ju Dzh.Vivratt[Us]
RU2108338C1
COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION 1992
  • Uil'Jam Dzh.Krist[Us]
  • Linn D.Khoukins[Us]
  • Osamu Asano[Jp]
  • Tsutomu Kavata[Jp]
  • Sejiti Kobajasi[Jp]
  • Daniehl' P.Rossin'Ol'[Us]
RU2095366C1
INHIBITORS OF HIV-PROTEASE 1994
  • Dzhoel R.Khaff
  • Dzhozef P.Vakka
  • Brjus D.Dorsi
RU2137768C1
METHOD OF PREPARING 7,7-DIOXIDE 5,6-DIHYDRO (S) -4- (ALKILAMINO)-(S)-6- ALKYL-4H- THIENO (2,3-b) THIOPYRAN - 2-SULFONAMIDE AND 7,7-DIOXIDE 5,6-DIHYDRO(S)-4- (ACYLAMIDO)-(S)-6-ALKYL-4H-THIENO (2,3-b)THIOPYRAN 1994
  • Pol Sokhar
  • Dehvid Dzh.Matr
  • Tomas Dzh.Blehklok
RU2114851C1
METHOD OF PREPARING 5-(1,2,4-TRIAZOL-1-YL)TRIPTAMINE COMPOUNDS, AND 2-[5- (1,2,4-TRIAZOL-1-YL)-1H-INDOL-3-YL]ETHANOL 1995
  • Cheng J.Chen
  • Robert D.Larsen
  • Tomas R.Verkhoehven
RU2138496C1

RU 2 114 105 C1

Authors

Dzhon J.A.Chang

Dehvid L.Kh'Judzhes

Dehlian Zao

Dates

1998-06-27Published

1993-02-23Filed